Blocking  	Blocking  	 VBG	O
initial  	initial  	 JJ	O
infiltration  	infiltration  	 NN	B-NP
of  	of  	 IN	I-NP
pioneer  	pioneer  	 CD	I-NP
CD8 	CD8 	 CD	I-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
T-cells  	T-cells  	 JJ	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
via  	via  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
SHP-2  	SHP-2  	 FW	B-NP
ameliorates  	ameliorates  	 FW	O
experimental  	experimental  	 FW	B-NP
autoimmune  	autoimmune  	 FW	I-NP
encephalomyelitis  	encephalomyelitis  	 FW	I-NP
in  	in  	 IN	O
mice  	mice  	 NNS	O
In  	In  	 IN	O
contrast  	contrast  	 NN	O
to  	to  	 TO	O
T-cell  	T-cell  	 JJ	B-NP
priming  	priming  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
periphery 	periphery 	 NN	O
,  	,  	 ,	O
therapeutic  	therapeutic  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
targeting  	targeting  	 VBG	O
the  	the  	 DT	O
initiation  	initiation  	 JJ	B-NP
step  	step  	 NN	I-NP
of  	of  	 IN	I-NP
T-cell  	T-cell  	 JJ	I-NP
trafficking  	trafficking  	 NN	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
have  	have  	 VBP	O
not  	not  	 RB	O
been  	been  	 VBN	O
extensively  	extensively  	 RB	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
examined  	examined  	 VBD	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
NSC-87877 	NSC-87877 	 NNP	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
potent  	potent  	 FW	O
Src  	Src  	 FW	B-NP
homology  	homology  	 FW	I-NP
2-containing  	2-containing  	 FW	O
protein  	protein  	 FW	B-NP
tyrosine  	tyrosine  	 FW	I-NP
phosphatase  	phosphatase  	 JJ	I-NP
2  	2  	 CD	O
( 	( 	 -LRB-	O
SHP-2 	SHP-2 	 NNP	B-NP
)  	)  	 -RRB-	O
inhibitor 	inhibitor 	 NN	O
,  	,  	 ,	O
on  	on  	 IN	O
experimental  	experimental  	 JJ	B-NP
autoimmune  	autoimmune  	 JJ	I-NP
encephalomyelitis  	encephalomyelitis  	 NNS	I-NP
( 	( 	 -LRB-	O
EAE 	EAE 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
elucidated  	elucidated  	 VB	O
its  	its  	 PRP$	O
unique  	unique  	 JJ	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
action 	action 	 NN	O
.  	.  	 .	O
C57BL 	C57BL 	 CD	O
/ 	/ 	 CD	O
6  	6  	 CD	O
mice  	mice  	 NNS	O
were  	were  	 VBD	O
immunized  	immunized  	 VBN	O
with  	with  	 IN	O
myelin  	myelin  	 JJ	B-NP
oligodendrocyte  	oligodendrocyte  	 JJ	I-NP
glycoprotein35-55  	glycoprotein35-55  	 NN	I-NP
and  	and  	 CC	O
monitored  	monitored  	 VBN	O
for  	for  	 IN	O
clinical  	clinical  	 JJ	B-NP
severity  	severity  	 NN	I-NP
of  	of  	 IN	O
disease  	disease  	 NN	O
and  	and  	 CC	O
histopathological  	histopathological  	 JJ	B-NP
features  	features  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
CNS 	CNS 	 NNP	B-NP
.  	.  	 .	O
Levels  	Levels  	 NNS	O
of  	of  	 IN	O
cytokines  	cytokines  	 NN	B-NP
in  	in  	 IN	O
serum  	serum  	 NN	B-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
elisa 	elisa 	 NN	B-NP
.  	.  	 .	O
Effects  	Effects  	 NNS	O
of  	of  	 IN	O
NSC-87877  	NSC-87877  	 CD	B-NP
on  	on  	 IN	O
expressions  	expressions  	 NNS	O
of  	of  	 IN	O
chemokines  	chemokines  	 NN	B-NP
and  	and  	 CC	O
cytokines  	cytokines  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
quantitative  	quantitative  	 JJ	B-NP
PCR 	PCR 	 NNP	I-NP
.  	.  	 .	O
NSC-87877-treated  	NSC-87877-treated  	 NNP	B-NP
mice  	mice  	 NNS	I-NP
developed  	developed  	 VBD	O
conventional  	conventional  	 JJ	B-NP
TH  	TH  	 NNP	I-NP
1  	1  	 CD	O
and  	and  	 CC	O
TH  	TH  	 NNP	B-NP
17  	17  	 CD	O
responses 	responses 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
were  	were  	 VBD	O
highly  	highly  	 RB	O
resistant  	resistant  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
induction  	induction  	 NN	B-NP
of  	of  	 IN	I-NP
EAE 	EAE 	 NNP	I-NP
.  	.  	 .	O
NSC-87877  	NSC-87877  	 NNP	B-NP
decreased  	decreased  	 VBD	O
the  	the  	 DT	O
accumulation  	accumulation  	 NN	B-NP
of  	of  	 IN	I-NP
lymphocytes  	lymphocytes  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
and  	and  	 CC	O
increased  	increased  	 VBD	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
chemokine  	chemokine  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
CXCR7  	CXCR7  	 NN	I-NP
on  	on  	 IN	O
CD8 	CD8 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
T-cells 	T-cells 	 JJ	I-NP
.  	.  	 .	O
Adoptive  	Adoptive  	 JJ	B-NP
transfer  	transfer  	 NN	I-NP
of  	of  	 IN	I-NP
T-cells  	T-cells  	 JJ	I-NP
from  	from  	 IN	O
2D2-transgenic  	2D2-transgenic  	 CD	O
mice  	mice  	 NNS	O
restored  	restored  	 VBD	B-NP
EAE  	EAE  	 NNP	I-NP
susceptibility  	susceptibility  	 NN	I-NP
in  	in  	 IN	O
NSC-87877-treated  	NSC-87877-treated  	 CD	B-NP
mice 	mice 	 NNS	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
NSC-87877  	NSC-87877  	 NNP	B-NP
only  	only  	 RB	O
targets  	targets  	 VBZ	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
migration  	migration  	 NN	O
of  	of  	 IN	O
pioneer  	pioneer  	 JJ	B-NP
T-cells 	T-cells 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
T-cell-conditioned  	T-cell-conditioned  	 JJ	B-NP
SHP-2-deficient  	SHP-2-deficient  	 CD	I-NP
mice  	mice  	 NNS	I-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
NSC-87877  	NSC-87877  	 NNP	B-NP
were  	were  	 VBD	O
no  	no  	 DT	O
longer  	longer  	 RBR	O
resistant  	resistant  	 JJ	O
to  	to  	 TO	O
EAE 	EAE 	 NNP	B-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 DT	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
SHP-2  	SHP-2  	 NNP	B-NP
contributes  	contributes  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
amelioration  	amelioration  	 NN	B-NP
of  	of  	 IN	I-NP
EAE  	EAE  	 NNP	I-NP
by  	by  	 IN	O
NSC-87877 	NSC-87877 	 CD	B-NP
.  	.  	 .	O
NSC-87877  	NSC-87877  	 NNP	B-NP
almost  	almost  	 RB	O
completely  	completely  	 RB	O
abolished  	abolished  	 VBN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
EAE  	EAE  	 NNP	B-NP
by  	by  	 IN	O
blocking  	blocking  	 VBG	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
infiltration  	infiltration  	 NN	B-NP
of  	of  	 IN	I-NP
pioneer  	pioneer  	 CD	I-NP
CD8 	CD8 	 CD	I-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
T-cells  	T-cells  	 JJ	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
uninflamed  	uninflamed  	 JJ	B-NP
CNS 	CNS 	 NNP	I-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
reveal  	reveal  	 VBP	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
role  	role  	 NN	I-NP
for  	for  	 IN	I-NP
SHP-2  	SHP-2  	 CD	I-NP
in  	in  	 IN	O
regulating  	regulating  	 VBG	B-NP
EAE  	EAE  	 NNP	I-NP
pathogenesis  	pathogenesis  	 NN	I-NP
and  	and  	 CC	O
indicate  	indicate  	 VB	O
that  	that  	 IN	O
NSC-87877  	NSC-87877  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
candidate  	candidate  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
relapsing-remitting  	relapsing-remitting  	 JJ	O
multiple  	multiple  	 JJ	O
sclerosis 	sclerosis 	 NN	O
.  	.  	 .	O
